Gapping up
In reaction to strong earnings/guidance: NPD +12.1% (thinly traded), PAMT +8.1% (provided post merger update and outlook; said work continues and is progressing well on improving the company's credit facility to provide a global line more suited to the company's needs and growth plans; co also provided guidance), BBRY +8.3%, RH +7%, FINL +3.9%.
M&A news: ARIA +6.8% ( DailyMail discusses rumors that Jazz may acquire ARIA for $20/share).
Select financial related names showing strength: RBS +1.2%, BAC +0.9%, DB +0.8%, BNS +0.7%.
Metals/mining stocks trading higher: MUX +9.3% , AUQ +3%, HMY +2.9%, KGC+2% (upgraded to Neutral from Sell at Goldman), BHP +1.6%, RIO +1.4%, GDX +1.2%, NEM +1.1%, BBL +0.9%, GLD +0.2%, AA +0.5% (upgraded to Neutral from Underperform at Macquarie; tgt raised to $10 from $5).
A few battery names are modestly higher: BLDP +2.7%, FCEL +2.5%, TSLA +0.2% (NJ sales ban has been delayed for 15 days, according to reports)
Other news: IDRA +31.2% (announces positive top-line data in Phase 2 Trial of IMO-8400; Trial meets primary objective of demonstrating safety and tolerability over 12-week treatment period; IMO-8400 also demonstrates clinical proof-of-concept in psoriasis), EXAS +9.1% (confirms FDA Advisory Committee unanimously recommends approval of Cologuard), ICLD +6.2% (refutes allegations made against the company; InterCloud remains focused on operations and growth), ZNGA +4.7% (S.A.C. Capital discloses 5.3% passive stake in 13G filing), HALO +3.7% (announces Roche Marketing Authorization For MabThera SC for patients with common forms of Non-Hodgkin Lymphoma In European Union), MPO +3% (S.A.C. Capital discloses 5.0% passive stake in 13G filing), MERC+2.1% (announced the pricing of its previously announced underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $7.15 per share), TNET +2.1% (continued strength following yesterday's IPO), SFXE +1.6% (following yesterday's earnings weakness; co commented on 2014 marketing and sponsorship EBITDA of over $40 Million), BUD +1.5% (still checking), BAX +1.4% (Barron's profiles positive view on Baxter), PRGX +1.2% (announces $10 mln increase in stock repurchase program), TWC +1.2% (checking for naything new; ongoing M&A speculation in cable/broadcasting names), AWR +1.1% (announces 1.25 mln share repurchase program), FEYE +0.9% (modestly rebounding; Reuters discusses comments from Google (GOOG) researchers that news firms may be under attack by hackers ), FB +0.9% (still checking), BIDU +0.9% (won lawsuit over search results censorship, according to reports ), AMZN +0.6% (has denied repots of free video streaming service, according to reports ), QDEL +0.5% (receives FDA Clearance for AmpliVue hand-held molecular diagnostic test for Herpes Simplex Virus Types 1 and 2).
Analyst comments: CTSH +4% (upgraded to Overweight from Equal Weight at Morgan Stanley ), SCTY +3.7% (upgraded to Outperform from Mkt Perform at Raymond James), SNN +1.8% (upgraded to Buy from Add at Investec), PFSI +1.2% (upgraded to Outperform from Market Perform at Wells Fargo), TEVA +1.1% (target raised to $60 from $56 at Citigroup; added to US Focus list),LULU +1% (upgraded to Outperform from Underperform at Credit Agricole; tgt raised to $60 from $54), AGN +0.7% (target raised to $140 from $130 at Citigroup), INVN +0.7% (upgraded to Buy from Neutral at ROTH Capital)
M&A news: ARIA +6.8% ( DailyMail discusses rumors that Jazz may acquire ARIA for $20/share).
Select financial related names showing strength: RBS +1.2%, BAC +0.9%, DB +0.8%, BNS +0.7%.
Metals/mining stocks trading higher: MUX +9.3% , AUQ +3%, HMY +2.9%, KGC+2% (upgraded to Neutral from Sell at Goldman), BHP +1.6%, RIO +1.4%, GDX +1.2%, NEM +1.1%, BBL +0.9%, GLD +0.2%, AA +0.5% (upgraded to Neutral from Underperform at Macquarie; tgt raised to $10 from $5).
A few battery names are modestly higher: BLDP +2.7%, FCEL +2.5%, TSLA +0.2% (NJ sales ban has been delayed for 15 days, according to reports)
Other news: IDRA +31.2% (announces positive top-line data in Phase 2 Trial of IMO-8400; Trial meets primary objective of demonstrating safety and tolerability over 12-week treatment period; IMO-8400 also demonstrates clinical proof-of-concept in psoriasis), EXAS +9.1% (confirms FDA Advisory Committee unanimously recommends approval of Cologuard), ICLD +6.2% (refutes allegations made against the company; InterCloud remains focused on operations and growth), ZNGA +4.7% (S.A.C. Capital discloses 5.3% passive stake in 13G filing), HALO +3.7% (announces Roche Marketing Authorization For MabThera SC for patients with common forms of Non-Hodgkin Lymphoma In European Union), MPO +3% (S.A.C. Capital discloses 5.0% passive stake in 13G filing), MERC+2.1% (announced the pricing of its previously announced underwritten public offering of 7,000,000 shares of its common stock at a price to the public of $7.15 per share), TNET +2.1% (continued strength following yesterday's IPO), SFXE +1.6% (following yesterday's earnings weakness; co commented on 2014 marketing and sponsorship EBITDA of over $40 Million), BUD +1.5% (still checking), BAX +1.4% (Barron's profiles positive view on Baxter), PRGX +1.2% (announces $10 mln increase in stock repurchase program), TWC +1.2% (checking for naything new; ongoing M&A speculation in cable/broadcasting names), AWR +1.1% (announces 1.25 mln share repurchase program), FEYE +0.9% (modestly rebounding; Reuters discusses comments from Google (GOOG) researchers that news firms may be under attack by hackers ), FB +0.9% (still checking), BIDU +0.9% (won lawsuit over search results censorship, according to reports ), AMZN +0.6% (has denied repots of free video streaming service, according to reports ), QDEL +0.5% (receives FDA Clearance for AmpliVue hand-held molecular diagnostic test for Herpes Simplex Virus Types 1 and 2).
Analyst comments: CTSH +4% (upgraded to Overweight from Equal Weight at Morgan Stanley ), SCTY +3.7% (upgraded to Outperform from Mkt Perform at Raymond James), SNN +1.8% (upgraded to Buy from Add at Investec), PFSI +1.2% (upgraded to Outperform from Market Perform at Wells Fargo), TEVA +1.1% (target raised to $60 from $56 at Citigroup; added to US Focus list),LULU +1% (upgraded to Outperform from Underperform at Credit Agricole; tgt raised to $60 from $54), AGN +0.7% (target raised to $140 from $130 at Citigroup), INVN +0.7% (upgraded to Buy from Neutral at ROTH Capital)